Markers of Endothelial Dysfunction: E-selectin, Endothelin-1 and von Willebrand Factor in Patients with Coronary Heart Disease, Including in Combination with Type 2 Diabetes Mellitus

被引：2
|
作者：
Zhito, Alexey, V [1 ]
Iusupova, Alfia O. [1 ]
Privalova, Elena, V [1 ]
Khabarova, Natalia, V [1 ]
Belenkov, Yurii N. [1 ]
机构：
[1] IM Sechenov First Moscow State Med Univ, Sechenov Univ, Trubetskaya Ul 8-2, Moscow 119991, Russia
来源：
RATIONAL PHARMACOTHERAPY IN CARDIOLOGY | 2019年 / 15卷 / 06期
关键词：
ischemic heart disease; diabetes mellitus type 2; E-selectin; von Willebrand factor; endothelin-1; endothelial dysfunction; SOLUBLE E-SELECTIN; CIRCULATING ADHESION MOLECULES; ARTERY-DISEASE; INFLAMMATORY MARKERS; P-SELECTIN; GLUCOSE; ASSOCIATION; RISK; BIOMARKERS; DIAGNOSIS;
D O I：
10.20996/1819-6446-2019-15-6-892-899
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The prevalence of coronary heart disease (CHD) and type 2 diabetes mellitus (type 2 diabetes) in Russia and in the world continues to increase. Despite the prevention and optimization of therapy, CHD retains its leadership among all causes of death, and the mortality rate from type 2 diabetes and its complications gradually increases too. To improve the treatment of the above mentioned diseases, it is necessary to clarify the pathogenetic mechanisms of their development. The formation of endothelial dysfunction, characterized by an increase in the level of cell adhesion molecules and vasoconstriction, is a common link characteristic for the course and progression of CHD and type 2 diabetes. This article presents an analysis of pre-and clinical studies on the role of endothelial dysfunction markers: cell adhesion molecules (E-selectin), vasoconstriction (endothelin-1) and von Willebrand factor in patients with CHD, including those with type 2 diabetes mellitus.
引用
收藏
页码：892 / 899
页数：8
相关论文
共 50 条
  • [1] E-SELECTIN AS A MARKER OF ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH CORONARY ARTERY DISEASE INCLUDING THOSE WITH TYPE 2 DIABETES MELLITUS
    Zhito, A. V.
    Iusupova, A. O.
    Kozhevnikova, M. V.
    Shchendrygina, A. A.
    Privalova, E. V.
    Belenkov, Yu N.
    KARDIOLOGIYA, 2020, 60 (04) : 24 - 30
  • [2] Endothelial Activation Markers Soluble E-Selectin and von Willebrand Factor in Primary Hyperparathyroidism
    Lumachi, Franco
    Zanella, Simone
    Cella, Giuseppe
    Casonato, Alessandra
    Fallo, Franco
    IN VIVO, 2011, 25 (02): : 279 - 282
  • [3] Thrombomodulin, von Willebrand factor and E-selectin as plasma markers of endothelial damage/dysfunction and activation in pregnancy induced hypertension
    Nadar, SK
    Al Yemeni, E
    Blann, AD
    Lip, GYH
    THROMBOSIS RESEARCH, 2004, 113 (02) : 123 - 128
  • [4] Endothelin-1, nitric oxide and von Willebrand factor in hypertensive type 2 diabetic patients
    Ouviña, SM
    Palmer, L
    Sassetti, B
    ACTA BIOQUIMICA CLINICA LATINOAMERICANA, 2004, 38 (04): : 471 - 476
  • [5] Increased circulating endothelial cells in acute heart failure: Comparison with von Willebrand factor and soluble E-selectin
    Chong, AY
    Lip, GYH
    Freestone, B
    Blann, AD
    EUROPEAN JOURNAL OF HEART FAILURE, 2006, 8 (02) : 167 - 172
  • [6] The effects of exercise stress testing on soluble E-selectin, von Willebrand factor, and circulating endothelial cells as indices of endothelial damage/dysfunction
    Boos, Christopher J.
    Balakrishnan, Balu
    Lip, Gregory Y. H.
    ANNALS OF MEDICINE, 2008, 40 (01) : 66 - 73
  • [7] Endothelin-1 gene polymorphisms and diabetic kidney disease in patients with type 2 diabetes mellitus
    Zanatta, Claudete M.
    Crispim, Daisy
    Sortica, Denise A.
    Klassmann, Lucas P.
    Gross, Jorge L.
    Gerchman, Fernando
    Canani, Luis H.
    DIABETOLOGY & METABOLIC SYNDROME, 2015, 7
  • [8] The E-selectin S128R polymorphism is not a risk factor for coronary artery disease in patients with diabetes mellitus type 2
    Endler, G
    Exner, M
    Raith, M
    Marculescu, R
    Mannhalter, C
    Endler, L
    Wojta, J
    Huber, K
    Wagner, OF
    THROMBOSIS RESEARCH, 2003, 112 (1-2) : 47 - 50
  • [9] ROLE OF VON WILLEBRAND FACTOR IN TYPE 2 DIABETES MELLITUS PATIENTS
    Umadevi, B.
    Roopakala, M. S.
    Silvia, Wilma Delphine C. R.
    Kumar, Prasanna K. M.
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2016, 5 (81): : 6075 - 6079
  • [10] Circulating intercellular cell adhesion molecule-1, endothelin-1 and von Willebrand factor-markers of endothelial dysfunction in uncomplicated essential hypertension:: the effect of treatment with ACE inhibitors
    Hlubocká, Z
    Umnerová, V
    Heller, S
    Peleska, J
    Jindra, A
    Jáchymová, M
    Kvasnicka, J
    Horky, K
    Aschermann, M
    JOURNAL OF HUMAN HYPERTENSION, 2002, 16 (08) : 557 - 562
12345